Since Donald Trump winning in the US presidential election, Bitcoin price witnessed a massive rally with a surge of 60%. The ...

BTC.D nears resistance, signaling potential altcoin outperformance ahead. XLM Leads Gains: Stellar Lumens posts a 122% USD ...

Layer-1 blockchain Aptos (APT) has announced a plan to integrate fintech giant Stripe's payment services and the stablecoin ...

If the Senate confirms Bessent, the next person whose signature is on the front of paper U.S. currency will be a fan of ...

Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

The Bitcoin price closed on $100K, but MSTR stock plunged and the Crypto All-Stars presale blasted past $5 million.

On November 22, renowned (and infamous) investor Jim Cramer revealed his bullish stance — now, some are worried that BTC ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Binance traders short Bitcoin, signaling bearish sentiment and potential correction as key levels face increasing pressure.

BTC price behavior is either hinting at a deeper pullback or an RSI-fueled surge beyond $100,000, Bitcoin market observers ...

Despite Bitcoin's recent rally, on-chain data reveals the bull market still has plenty of room to grow. Metrics like the MVRV ...